Gluci Injection is a sterile parenteral formulation containing Calcium Gluconate (50 mg) and Calcium Lactobionate (87.5 mg) per milliliter, indicated for the treatment and prevention of hypocalcemia and related calcium deficiencies. This combination provides a bioavailable source of calcium essential for maintaining normal physiological functions, including neuromuscular activity, blood coagulation, and bone metabolism. Calcium Gluconate serves as a rapid-acting calcium supplement, while Calcium Lactobionate offers enhanced solubility and stability, facilitating effective calcium replenishment. Gluci Injection is primarily utilized in clinical scenarios such as acute hypocalcemia, tetany, calcium channel blocker overdose, and as an adjunct in the management of conditions like osteoporosis and rickets where calcium supplementation is warranted. The injection is administered intravenously or intramuscularly under medical supervision, with dosage tailored according to patient age, severity of deficiency, and clinical response. Caution is advised in patients with hypercalcemia, renal impairment, or cardiac arrhythmias. Adverse reactions may include local irritation, hypercalcemia symptoms, or hypersensitivity reactions. Proper monitoring of serum calcium levels is recommended during therapy to avoid complications. Gluci Injection should be stored at controlled room temperature and protected from light to maintain stability and efficacy.